“Rogue” neutrophil-subset [DEspR+CD11b+/CD66b+] immunotype is an actionable therapeutic target for neutrophilic inflammation-mediated tissue injury – studies in human, macaque and rat LPS-inflammation models
暂无分享,去创建一个
J. Hohlfeld | V. Herrera | Meike Müller | N. Ruiz‐Opazo | S. Carstensen | Glaiza L. A. Tan | K. A. Pasion